SCHEMBL8744201

SCHEMBL8744201

Cc1cn([C@@]2(C(=S)Oc3ccccc3)C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RNASE1 P07998 1/20 0.40
TK2 O00142 2/20 0.38
TK1 P04183 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3694341 0.83 TK1 (0.43) RNASE1TK1
SCHEMBL5148089 0.83 RNASE1 (0.46) RNASE1TK2TK1
SCHEMBL6536213 0.80 TK1 (0.42) TK1
SCHEMBL6923545 0.79 RNASE1 (0.41) RNASE1TK2TK1
SCHEMBL6923541 0.79 RNASE1 (0.41) RNASE1TK2TK1
SCHEMBL28239487 0.79 TK1 (0.41) TK1
SCHEMBL27651863 0.79 TK1 (0.41) TK2TK1
SCHEMBL28293851 0.79 TK1 (0.39) RNASE1TK1
SCHEMBL29927067 0.79 RNASE1 (0.39) RNASE1TK2TK1
SCHEMBL17224727 0.78 TK1 (0.39) RNASE1TK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0753002-A1 MODIFIED OLIGONUCLEOTIDES AND INTERMEDIATES USEFUL IN NUCLEIC ACID THERAPEUTICS AMGEN INC. (US) 1997-01-15 EP disclosed
WO-1995026972-A1 MODIFIED OLIGONUCLEOTIDES AND INTERMEDIATES USEFUL IN NUCLEIC ACID THERAPEUTICS AMGEN INC. (US) 1995-10-12 WO disclosed